Direct Flow Medical Inc. presented three-year results from its prospective, multicenter DISCOVER Trial at the EuroPCR meeting in Paris.
Using optimal frequency domain imaging (OFDI) to guide percutaneous coronary intervention (PCI) with second-generation drug eluting stents (DES) achieves equivalent clinical and angiographic outcomes to intravascular ultrasound (IVUS)-guided PCI at 12 months.
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater risk of ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Physician-researchers in the College of Medicine at the University of Cincinnati have developed a computerized decision support tool to assist physicians and patients with decisions about blood thinning treatment to prevent strokes in individuals with atrial fibrillation.
BioVentrix announced the first-in-man use of its next-generation Revivent-TC System with an endovascular catheter-based approach from within the left ventricle.
St. Jude Medical Inc. announced results from two cardiovascular clinical trials presented at EuroPCR 2016.
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
There were many opinions on the duration of dual antiplatelet therapy (DAPT) highlighted at the 2016 American College of ...
Bioabsorbable heart valves or blood vessels are designed to harness the body’s innate healing process, enabling the natural restoration of complex body parts as the synthetic graft is absorbed.
The TRANSFORM trial was designed to evaluate the safety and performance of an investigational rapid deployment aortic valve replacement (RDAVR) system for patients with severe aortic stenosis.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
May 18, 2016 — The Intersocietal Accreditation Commission (IAC) recently announced its launch of the IAC QI Self ...
NeoChord Inc. announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin a prospective, multicenter, randomized clinical trial for its Artificial Chordae Delivery System, DS1000.
Biotronik presented 12-month data from the BIOSOLVE-II trial during a Hotline Session at EuroPCR 2016.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Science fiction offers a lot of ideas for creating new body parts on demand, and the advancement of 3-D printing (also ...
May 17, 2016 — An interdisciplinary Johns Hopkins University team has developed a non-invasive 3-D virtual heart ...
Macadamian Technologies, a user experience research, design and software development firm, recently announced the completion of a comprehensive usability test of Siemens Acuson S3000 ultrasound system, HELX Evolution with Touch Control.
May 20, 2016
